Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and atorvastatin in compensated cryptogenic cirrhosis
IRCT2016120531252N1Phase 3Completed
- Sponsor
- Office of Research & Technology, Qom University of Medical Sciences
- Start
- Jan 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aspirin and atorvastatin in Cirrhosis, sponsored by Office of Research & Technology, Qom University of Medical Sciences. Started Jan 2017; status: completed.
02
Drugs
aspirinatorvastatin
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on IRCT2016120531252N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016120531252N1.